17 Minutes of Science
17 Minutes of Science
InVivo Biosystems
Episode 43: rare Disease Drug Development with Dr. Ethan Perlstein (Founder & CEO of Perlara PBC)
17 minutes Posted Apr 20, 2021 at 7:58 pm.
0:00
17:57
Download MP3
Show notes

For episode 43 of 17 Minutes of Science we are joined by Dr. Ethan Perlstein of Perlara PBC.

Dr. Perlstein is the CEO and founder of Perlara, a company on a mission to accelerate the discovery of cures for rare genetic diseases and uncover underlying mechanisms that enable the development of treatments that work across a range of diseases and individuals.

Ethan has been passionate about Rare Disease for more than a decade. Starting with PhD in Harvard's Stuart Schreiber lab. Then, as a postdoctoral fellow in the Lewis-Sigler Institute at Princeton, Ethan has been championing finding new purpose in old drugs. 19 peer-reviewed has culminated in his involvement in multiple startups, all focusing on Rare Disease. He has become a tireless champion for helping families of Rare Disease to solve their Diagnostic Odyssey and find new drug. His big focus, how to you find the most cost efficiently repurpose old drugs for new use in Rare Disease.

Tune in to episode 43 to learn more about Dr. Perlstein, Perlara, and developing treatment options for rare diseases.